Skip to main content

Table 2 The clinical characteristics of the replicate cohort MS patients at the end of the study categorized by rs2304166 genotypes

From: GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients

Rs2304166 genotype (N = 86) Pre-NTZ treatment Post 2-year NTZ treatment
EDSS [Median (IQRa)] EDSS [Median (IQR)] New CNS lesion (n) Relapse (n)
GG 3.5 (2.5–4.5) 3 (2–4.75) 0 0
GC 2 (2.5–4.25) 2 (1.5–4.25) 0 0
CC 3.5 (2–5.87) 5.25 (2–6.5) 2 2
  1. aIQR Interquartile range